Drug intelligence / Profile preview

diclofenac potassium + lidocaine

Development stage
Unknown
Lead developer
Teligent Pharma
Modality
Small Molecules
Administration
Topical, Transdermal, Oral
01

Overview

Diclofenac potassium + lidocaine is a combination medication that pairs two active ingredients with complementary mechanisms of action for pain relief. Diclofenac potassium is a non-steroidal anti-inflammatory drug (NSAID) that works by blocking cyclooxygenase enzymes (COX-1 and COX-2), which reduces the production of prostaglandins responsible for pain and inflammation[4]. Lidocaine is a local anesthetic that numbs nerves by blocking sodium-potassium channels, making them less sensitive to pain signals[3][4]. This combination is used for various pain conditions, including arthritis pain, musculoskeletal pain, and procedural pain. Clinical studies have shown that the combination slightly reduces pain scores during procedures like intrauterine device (IUD) insertion, though the reduction may not always reach clinical significance[1]. The topical formulation allows for local pain relief while potentially reducing systemic side effects compared to oral administration of NSAIDs[3][5].

Brand names
Diclona
Other names
diclofenac and lidocaine topicaldiclofenac / lidocaine gel
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NaV (Voltage-gated sodium channels)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on diclofenac potassium + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diclofenac potassium + lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call